Cargando…

JUN mediates glucocorticoid resistance by stabilizing HIF1a in T cell acute lymphoblastic leukemia

Dexamethasone (Dex) plays a critical role in T-ALL treatment, but the mechanisms of Dex resistance are poorly understood. Here, we demonstrated that the expression of JUN was regulated in Dex-resistant T-ALL cell lines and patient samples. JUN knockdown increased the sensitivity to Dex. Moreover, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhijie, Shi, Jiangzhou, Wu, Qifang, Zhang, Zijian, Liu, Xiaoyan, Ren, Anqi, Zhao, Guanlin, Dong, Ge, Wu, Han, Zhao, Jiaxuan, Zhao, Yuan, Hu, Jia, Li, Hui, Zhang, Tongcun, Zhou, Fuling, Zhu, Haichuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661119/ https://www.ncbi.nlm.nih.gov/pubmed/38026210 http://dx.doi.org/10.1016/j.isci.2023.108242

Ejemplares similares

CAR T cells targeting CD99 as an approach to eradicate T-cell acute lymphoblastic leukemia without normal blood cells toxicity
por: Shi, Jiangzhou, et al.
Publicado: (2021)

Direct inhibition of dioxygenases TET1 by the rheumatoid arthritis drug auranofin selectively induces cancer cell death in T-ALL
por: Chen, Long, et al.
Publicado: (2023)

CAR T-Cell Immunotherapy Treating T-ALL: Challenges and Opportunities
por: Ren, Anqi, et al.
Publicado: (2023)

A novel method to establish glucocorticoid resistant acute lymphoblastic leukemia cell lines
por: Gu, Ling, et al.
Publicado: (2019)

Gene Mutations Related to Glucocorticoid Resistance in Pediatric Acute Lymphoblastic Leukemia
por: Zhang, JinFang, et al.
Publicado: (2022)

Targeting chemokines for acute lymphoblastic leukemia therapy
por: Hong, Zixi, et al.
Publicado: (2021)

Modeling the Mechanism of GR/c-Jun/Erg Crosstalk in Apoptosis of Acute Lymphoblastic Leukemia
por: Chen, Daphne Wei-Chen, et al.
Publicado: (2012)

The prognostic value of glucocorticoid receptors for adult acute lymphoblastic leukemia
por: Bedewy, Ahmed M. L., et al.
Publicado: (2015)

Glucocorticoid-mediated BIM induction and apoptosis are regulated by Runx2 and c-Jun in leukemia cells
por: Heidari, N, et al.
Publicado: (2012)

Integrated genomic analyses identify high-risk factors and actionable targets in T-cell acute lymphoblastic leukemia
por: Zhu, Haichuan, et al.
Publicado: (2022)

Functionally distinct patterns of nucleosome remodeling at enhancers in glucocorticoid-treated acute lymphoblastic leukemia
por: Wu, Jennifer N., et al.
Publicado: (2015)

Metabolic reprogramming of acute lymphoblastic leukemia cells in response to glucocorticoid treatment
por: Dyczynski, Matheus, et al.
Publicado: (2018)

Dasatinib overcomes glucocorticoid resistance in B-cell acute lymphoblastic leukemia
por: Sarno, Jolanda, et al.
Publicado: (2023)

PLZF/ZBTB16, a glucocorticoid response gene in acute lymphoblastic leukemia, interferes with glucocorticoid-induced apoptosis
por: Wasim, Muhammad, et al.
Publicado: (2010)

Reversal of glucocorticoid resistance in Acute Lymphoblastic Leukemia cells by miR-145
por: Long, Sili, et al.
Publicado: (2020)

Emerging Epigenetic and Posttranslational Mechanisms Controlling Resistance to Glucocorticoids in Acute Lymphoblastic Leukemia
por: Borin, Cristina, et al.
Publicado: (2023)

The third-generation anti-CD30 CAR T-cells specifically homing to the tumor and mediating powerful antitumor activity
por: Zhang, Shangkun, et al.
Publicado: (2022)

Association Between NR3C1 Mutations and Glucocorticoid Resistance in Children With Acute Lymphoblastic Leukemia
por: Liu, Haiyan, et al.
Publicado: (2021)

Integrated bioinformatics analysis of the crucial candidate genes and pathways associated with glucocorticoid resistance in acute lymphoblastic leukemia
por: Chen, Yanxin, et al.
Publicado: (2020)

The synthetic glucocorticoids prednisolone and dexamethasone regulate the same genes in acute lymphoblastic leukemia cells
por: Bindreither, Daniel, et al.
Publicado: (2014)

Overcoming Glucocorticoid Resistance in Acute Lymphoblastic Leukemia: Repurposed Drugs Can Improve the Protocol
por: Olivas-Aguirre, Miguel, et al.
Publicado: (2021)

A Multicenter Cohort Study on Children Suffering from Acute Lymphoblastic Leukemia: Effects of Obesity on Mortality
por: Wang, Xiangwen, et al.
Publicado: (2022)

A semantics-oriented computational approach to investigate microRNA regulation on glucocorticoid resistance in pediatric acute lymphoblastic leukemia
por: Chen, Huiqin, et al.
Publicado: (2018)

3D genome alterations associated with dysregulated HOXA13 expression in high-risk T-lineage acute lymphoblastic leukemia
por: Yang, Lu, et al.
Publicado: (2021)

Health utility of children with acute lymphoblastic leukemia in China
por: Wang, Wei, et al.
Publicado: (2023)

Identification of hub genes and molecular mechanisms in infant acute lymphoblastic leukemia with MLL gene rearrangement
por: Zhang, Hao, et al.
Publicado: (2019)

PI3K inhibition synergizes with glucocorticoids but antagonizes with methotrexate in T-cell acute lymphoblastic leukemia
por: Silveira, André Bortolini, et al.
Publicado: (2015)

Translational profiling in childhood acute lymphoblastic leukemia: no evidence for glucocorticoid regulation of mRNA translation
por: Aneichyk, Tatsiana, et al.
Publicado: (2013)

Glucocorticoid-resistant B cell acute lymphoblastic leukemia displays receptor tyrosine kinase activation
por: Chougule, Rohit A., et al.
Publicado: (2019)

Age-related differences of genetic susceptibility to patients with acute lymphoblastic leukemia
por: Hao, Qing, et al.
Publicado: (2021)

Identification of co-expressed genes associated with MLL rearrangement in pediatric acute lymphoblastic leukemia
por: Zhang, Hao, et al.
Publicado: (2020)

Genetic and Epigenetic Targeting Therapy for Pediatric Acute Lymphoblastic Leukemia
por: Xu, Huan, et al.
Publicado: (2021)

Clinical characteristics and prognosis of pediatric patients with B cell acute lymphoblastic leukemia relapse
por: Zhang, Xiaohong, et al.
Publicado: (2018)

WEE1 inhibition induces glutamine addiction in T-cell acute lymphoblastic leukemia
por: Hu, Juncheng, et al.
Publicado: (2020)

Characteristics in gut microbiome is associated with chemotherapy-induced pneumonia in pediatric acute lymphoblastic leukemia
por: Liu, Xiaoming, et al.
Publicado: (2021)

Recent advances on blinatumomab for acute lymphoblastic leukemia
por: Zhao, Juanjuan, et al.
Publicado: (2019)

Influence of wild-type MLL on glucocorticoid sensitivity and response to DNA-damage in pediatric acute lymphoblastic leukemia
por: Beesley, Alex H, et al.
Publicado: (2010)

Pharmacogenomic Markers of Glucocorticoid Response in The Initial Phase of Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia
por: Gasic, Vladimir, et al.
Publicado: (2018)

Mutual antagonism between glucocorticoid and canonical Wnt signaling pathways in B-cell acute lymphoblastic leukemia
por: Bergeron, Brennan P., et al.
Publicado: (2023)

Combination therapy of BCR-ABL-positive B cell acute lymphoblastic leukemia by tyrosine kinase inhibitor dasatinib and c-JUN N-terminal kinase inhibition
por: Xiao, Xinhua, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6bdhsu971dm6eatcmtvbf67p3a